Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65.
Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
Levin SE, Blumberg H, Zamit R, et al. Mucoviscidosis (cystic fibrosis of the pancreas) in Bantu twin neonates. S Afr Med J 1967;41:482-5.
Grove SS. Fibrocystic disease of the pancreas in the Bantu. S Afr J Lab Clin Med 1959;5:113-9.
Wang CI, Sumi WT, Stanton R, et al. Cystic fibrosis in an Oriental child. N Engl J Med 1968;279:1216-8.
Demay G, Cheron G, Challier P, et al. [Cystic fibrosis in an African child. Apropos of a case]. Arch Fr Pediatr 1984;41:370.
Padoa C, Goldman A, Jenkins T, et al. Cystic fibrosis carrier frequencies in populations of African origin. J Med Genet 1999;36:41-4.
Goldman A, Labrum R, Claustres M, et al. The molecular basis of cystic fibrosis in South Africa. Clin Genet 2001;59:37-41.
Rippon I, Lewison G, Partridge MR. Research outputs in respiratory medicine. Thorax 2005;60:63-7.
Phillips RJ, Crock CM, Dillon MJ, et al. Cystic fibrosis presenting as kwashiorkor with florid skin rash. Arch Dis Child 1993;69:446-8.
Felley C, Morris MA, Wonkam A, et al. The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study. AIDS 2004;18:1521-7.
Hoyer HX, Schmid H, Gamarra F, et al. Cystic fibrosis diagnosed in a 38-year-old man with long-standing HIV infection. Clin Infect Dis 2004;39:438-9.
Carles S, Desgeorges M, Goldman A, et al. First report of CFTR mutations in black cystic fibrosis patients of southern African origin. J Med Genet 1996; 33:802-4.
Monnier N, Gout JP, Pin I, et al. A novel 3600+11.5 kb C>G homozygous splicing mutation in a black African, consanguineous CF family. J Med Genet 2001;38:E4.
Feuillet-Fieux MN, Ferrec M, Gigarel N, et al. Novel CFTR mutations in black cystic fibrosis patients. Clin Genet 2004;65:284-7.
Macek M Jr, Mackova A, Hamosh A, et al. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet 1997; 60:1122-7.
de Onis M, Monteiro C, Akre J, et al. The worldwide magnitude of protein-energy malnutrition: an overview from the WHO Global Database on Child Growth. Bull World Health Organ 1993;71:703-12.
Gernaat HB, Dechering WH, Voorhoeve HW. Mortality in severe protein-energy malnutrition at Nchelenge, Zambia. J Trop Pediatr 1998;44:211-7.
Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol 2006;20:531-46.
Olson DL, Schwenk WF II. Nutrition for patients with cystic fibrosis. Nutr Clin Pract 2004;19:575-80.
Macallan DC. Malnutrition in tuberculosis. Diagn Microbiol Infect Dis 1999;34:153-7.
Boelaert JR, Gordeuk VR. Protein energy malnutrition and risk of tuberculosis infection. Lancet 2002;360:1102.
Hamosh A, FitzSimmons SC, Macek M Jr, et al. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 1998; 132:255-9.
Rozmahel R, Wilschanski M, Matin A, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 1996; 12:280-7.
Rosenstein BJ. What is a cystic fibrosis diagnosis? Clin Chest Med 1998;19:423-41.
Rodrigues ME, Melo MC, Reis FJ, et al. Concentration of electrolytes in the sweat of malnourished children. Arch Dis Child 1994;71:141-3.
Yigit H, Selimoglu MA, Altinkaynak S. Sweat test results in children with primary protein energy malnutrition. J Pediatr Gastroenterol Nutr 2003;37:242-5.
Mutesa L, Azad AK, Verhaeghe C, et al. Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants. Chest 2009;135:1233-42.
Goldman A, Graf C, Ramsay M, et al. Molecular diagnosis of cystic fibrosis in South African populations. S Afr Med J 2003;93:518-9.
Westwood T, Henderson B, Ramsay M. Diagnosing cystic fibrosis in South Africa. S Afr Med J 2006; 96:304-6.
Cutting GR, Kasch LM, Rosenstein BJ, et al. A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature 1990;346:366-9.
Cutting GR, Curristin SM, Nash E, et al. Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet 1992;50:1185-94.
White MB, Krueger LJ, Holsclaw DS Jr, et al. Detection of three rare frameshift mutations in the cystic fibrosis gene in an African-American (CF444delA), an Italian (CF2522insC), and a Soviet (CF3821delT). Genomics 1991;10:266-9.
Ober C, Lester LA, Mott C, et al. Ethnic heterogeneity and cystic fibrosis transmembrane regulator (CFTR) mutation frequencies in Chicago-area CF families. Am J Hum Genet 1992;51:1344-8.
Smit LS, Strong TV, Wilkinson DJ, et al. Missense mutation (G480C) in the CFTR gene associated with protein mislocalization but normal chloride channel activity. Hum Mol Genet 1995;4:269-73.
Smit LS, Nasr SZ, Iannuzzi MC, et al. An African-American cystic fibrosis patient homozygous for a novel frameshift mutation associated with reduced CFTR mRNA levels. Hum Mutat 1993;2:148-51.
Wang YL, Chen KL, Joshi II, et al. A novel missense mutation, R1283S, of the cystic fibrosis transmembrane conductance regulator gene in a 47-year-old African-American patient. Mol Diagn 1997;2:205-8.
Monaghan KG, Bluhm D, Phillips M, et al. Preconception and prenatal cystic fibrosis carrier screening of African Americans reveals unanticipated frequencies for specific mutations. Genet Med 2004; 6:141-4.
Alper OM, Wong LJ, Young S, et al. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients. Hum Mutat 2004;24:353.
Friedman KJ, Leigh MW, Czarnecki P, et al. Cystic fibrosis transmembrane-conductance regulator mutations among African Americans. Am J Hum Genet 1998;62:195-6.
Dork T, El-Harith EH, Stuhrmann M, et al. Evidence for a common ethnic origin of cystic fibrosis mutation 3120+1G->A in diverse populations. Am J Hum Genet 1998;63:656-62.
Sugarman EA, Rohlfs EM, Silverman LM, et al. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med 2004;6:392-9.
Raskin S, Pereira L, Reis F, et al. High allelic heterogeneity between Afro-Brazilians and Euro-Brazilians impacts cystic fibrosis genetic testing. Genet Test 2003;7:213-8.
Westwood T, Brown R. Cystic fibrosis in black patients: Western Cape experiences. S Afr Med J 2006;96:288-9.
Romey MC, Guittard C, Carles S, et al. First putative sequence alterations in the minimal CFTR promoter region. J Med Genet 1999;36:263-4.
des Georges M, Guittard C, Templin C, et al. WGA allows the molecular characterization of a novel large CFTR rearrangement in a Black South African cystic fibrosis patient. J Mol Diagn 2008;10:544-8.
Collazo T, Bofill AM, Clark Y, et al. Common mutations in Cuban cystic fibrosis patients. J Cyst Fibros 2009;8:47-9.
Cabello GM, Cabello EHJJL, Fernande O, et al. The 3120 +1G->A splicing mutation in CFTR is common in Brazilian cystic fibrosis patients. Hum Biol 2001; 73:403-9.
el-Harith EA, Dork T, Stuhrmann M, et al. Novel and characteristic CFTR mutations in Saudi Arab children with severe cystic fibrosis. J Med Genet 1997; 34:996-9.
Tzetis M, Kanavakis E, Antoniadi T, et al. Characterization of more than 85% of cystic fibrosis alleles in the Greek population, including five novel mutations. Hum Genet 1997;99:121-5.
Kerem BS, Zielenski J, Markiewicz D, et al. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci USA 1990;87:8447-51.
Nunes V, Gasparini P, Novelli G, et al. Analysis of 14 cystic fibrosis mutations in five south European populations. Hum Genet 1991;87:737-8.
Strandvik B, Bjorck E, Fallstrom M, et al. Spectrum of mutations in the CFTR gene of patients with classical and atypical forms of cystic fibrosis from southwestern Sweden: identification of 12 novel mutations. Genet Test 2001;5:235-42.
Alibakhshi R, Kianishirazi R, Cassiman JJ, et al. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations. J Cyst Fibros 2008;7:102-9.
Bobadilla JL, Macek M Jr, Fine JP, et al. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 2002;19:575-606.
Boucher RC. Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 2007;261:5-16.
Frizzell RA, Pilewski JM. Finally, mice with CF lung disease. Nat Med 2004;10:452-4.
Boucher RC. Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends Mol Med 2007;13:231-40.
Stutts MJ, Canessa CM, Olsen JC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995;269:847-50.
Mall M, Grubb BR, Harkema JR, et al. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004; 10:487-93.
Sheridan MB, Fong P, Groman JD, et al. Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome. Hum Mol Genet 2005;14:3493-8.
Viel M, Leroy C, Hubert D, et al. ENaCbeta and gamma genes as modifier genes in cystic fibrosis. J Cyst Fibros 2008;7:23-9.
